About

Trait Biosciences is a biotechnology research company based in Los Alamos, New Mexico.


Our team of scientists and USA/Canada collaborators are developing cannabis/hemp specific products which provide for:

- Patent pending – RNAi crop protection specifically designed to reduce use of pesticides and fungicides and reduce accumulation of fungal toxins.

- Patent pending production of water-soluble full-spectrum cannabinoids for enhanced product formulations, controlled release and greater bioavailability.

- Patent pending novel technology to substantially increase cannabinoid production and accumulation.

Operating Team

Kimberly Harrison

Chief Executive Officer
  • 25 years experience as an entrepreneur across industries
  • Experienced in strategy, product development, VC funding, patents, distribution/licensing and government relations
  • Served on numerous international product certification and standardization committees

Dr. Richard Sayre

Chief Scientific Officer
  • Leading Research Scientists at Los Alamos National Laboratory and the New Mexico Consortium
  • Extensive biotech experience in universities, national laboratories, and the private sector
  • One of the top 5 crop scientists who could change the world, according to Nature journal
  • Author of over 130 biotechnology papers and patents, with over 7000 citations
  • Received over US$100 million in grant funding for various projects

Erik Briones

Chief Operating Officer
  • Leading Research Scientists at Los Alamos National Laboratory and the New Mexico Consortium
  • Extensive biotech experience in universities, national laboratories, and the private sector
  • One of the top 5 crop scientists who could change the world, according to Nature journal
  • Author of over 130 biotechnology papers and patents, with over 7000 citations
  • Received over US$100 million in grant funding for various projects

Edward Cheung

Chief Development Officer
  • Over 20 years experience at global investment banks including JPMorgan, Lehman Brothers and Credit Suisse, advising on equities and derivatives to institutions, hedge funds and sovereign wealth funds
  • Experience in setting up new businesses including a trading division at a US bank and board member of several startups
     

David Smalley

Chief Council
  • 17 years practising corporate and securities law, providing legal services for financing private and public companies
  • Director of number of Capital Pool Companies listed for trading on TSX-Venture Exchange in Canada
  • Advises CEOs on financing and business strategies; provides corporate, commercial and securities legal services

Dr. Rick Derose

Director of innovation
  • One of the top Research Scientists at Los Alamos National Laboratory and the New Mexico Consortium Extensive biotech experience in universities, national laboratories, and the private sector
  • One of the top 5 crop scientists who could change the world, according to Nature journal Author of over 130 biotechnology papers and patents, with over 7000 citations
  • Received over US$100 million in grant funding for various projects

Eugene Hodgson

Chief financial officer
  • Accomplished senior executive in both private industry as a banker, financial and public policy advisor
  • Experienced negotiator with First Nations groups and strategic board member for a number of business and community associations
  • Director and Audit Chair of Pebble Labs Inc., Maxtech Ventures Inc., Rover Metals Inc, and Red Fund Capital Corp

Board of Directors & Scientific Advisory Board


Michael Harrison

Chairman of the board
  • 35 years experience in investment banking with interests in the resource, energy and biotech sectors
  • Responsible for raising in excess of US$1 billion in funding for private and publicy traded companies
  • Served on the Board of Directors for numerous international publicly listed companies

Edward Cheung

Director
  • Over 20 years experience at global investment banks including JPMorgan, Lehman Brothers and Credit Suisse, advising on equities and derivatives to institutions, hedge funds and sovereign wealth funds
  • Experience in setting up new businesses including a trading division at a US bank and board member of several startups

David Smalley

Director
  • 17 years practising corporate and securities law, providing legal services for financing private and public companies
  • Director of number of Capital Pool Companies listed for trading on TSX-Venture Exchange in Canada
  • Advises CEOs on financing and business strategies; provides corporate, commercial and securities legal services

Dr. Norman G. Lewis

Scientific Advisor
  • Chief Research Scientist at the New Mexico Consortium, with over 40 years experience as a biochemist
  • Research Fellow at the New Center for Genomic Resources and President at Ealasid Inc.
  • Current research interests are largely in discovering/studying/modifying plant biochemical pathways, as well as with bioenergy/bioproducts and medicinal plant biosynthetic pathway research

Dr. Omar Hulgain

Dept. of Plant and Environmental Science
  • Chief Research Scientist at the New Mexico Consortium, with over 40 years experience as a biochemist
  • Research Fellow at the New Center for Genomic Resources and President at Ealasid Inc.
  • Current research interests are largely in discovering/studying/modifying plant biochemical pathways, as well as with bioenergy/bioproducts and medicinal plant biosynthetic pathway research
//]]>